A new tweak to Brain-Stimulating implants may speed seizure relief

NCT ID NCT07725601

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a modified programming method for an implanted vagus nerve stimulation (VNS) device can reduce seizures faster than the standard approach in adults with epilepsy. Participants will attend up to three study visits every three months for two years, keep a seizure diary, and answer questionnaires about quality of life and thinking skills. The goal is to see if the new programming, called the Augusta Way, offers quicker seizure control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a modified programming method for an implanted vagus nerve stimulation (VNS) device
What this could lead to
If it works, this could offer a faster way to reduce seizures in people with epilepsy who use a VNS device.
What could go wrong
This is a small, early-stage trial comparing two programming approaches, so results may not apply broadly. The modified method could cause unexpected side effects or fail to improve seizure control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wellstar MCG Hospital

    RECRUITING

    Augusta, Georgia, 30912, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.